The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
The bromodomain and extraterminal (BET) family member BRD4 is pivotal in the pathogenesis of cardiac hypertrophy. BRD4 induces hypertrophic gene expression by binding to the acetylated chromatin, facilitating the phosphorylation of RNA polymerases II (Pol II) and leading to transcription elongation....
Main Authors: | Zhenzhen Li, Zhen Guo, Rui Lan, Sidong Cai, Zhirong Lin, Jingyan Li, Junjian Wang, Zhuoming Li, Peiqing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383520308455 |
Similar Items
-
PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
by: Ahrum Min, et al.
Published: (2020-02-01) -
The Multifactorial Role of PARP-1 in Tumor Microenvironment
by: Juan Manuel Martí, et al.
Published: (2020-03-01) -
Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis
by: Bo-Hua Jiang, et al.
Published: (2015-07-01) -
Etude de la Poly(ADP-ribosyl)ation dans un contexte des cassures double-brins des ADN nucléaire et mitochondriaux chez Drosophila melanogaster
by: Ishak, Layal
Published: (2016) -
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells
by: Sabine Hombach‐Klonisch, et al.
Published: (2019-02-01)